CRISPR THERAPEUTICS AG

Ticker: CRSP CUSIP: H17182108 Class: NAMEN AKT

Mayflower Financial Advisors, LLC's Holding History (CIK: 0001852930)

Note: Option positions (PUT/CALL) are excluded.

Q2 2024
Shares 13,558 Value ($000) $79 Avg Close $57.84 Range $51.02 - $68.39
Q1 2024
Shares 13,366 Value ($000) $80 Avg Close $71.59 Range $58.29 - $91.10
Q4 2023
Shares 12,586 Value ($000) $25 Avg Close $55.02 Range $37.55 - $76.97
Q3 2023
Shares 12,578 Value ($000) $21 Avg Close $51.65 Range $44.53 - $59.67
Q2 2023
Shares 12,586 Value ($000) $24 Avg Close $56.74 Range $43.10 - $72.00
Q1 2023
Shares 12,586 Value ($000) $22 Avg Close $48.57 Range $39.88 - $58.50
Q4 2022
Shares 12,623 Value ($000) $22 Avg Close $53.05 Range $38.94 - $66.31
Q3 2022
Shares 12,636 Value ($000) $29 Avg Close $72.47 Range $60.41 - $86.95
Q2 2022
Shares 12,636 Value ($000) $28 Avg Close $58.79 Range $42.51 - $75.42
Q1 2022
Shares 12,978 Value ($000) $50 Avg Close $62.79 Range $50.54 - $79.40